COST-EFFECTIVENESS ANALYSIS OF FILGOTINIB VERSUS TOFACITINIB AS FIRST-LINE TREATMENTS FOR RHEUMATOID ARTHRITIS IN GREECE

被引：0
|
作者：
Nomikos, N. [1 ]
Naoum, P. [1 ]
Athanasakis, K. [1 ]
Kyriopoulos, I [2 ]
机构：
[1] Univ West Attica, Athens, Greece
[2] London Sch Econ & Polit Sci, London, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE134
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUSCOMBOTHERAPY FIRST LINE FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN GREECE
    Athanasakis, K.
    Tarantilis, F.
    Skroumpelos, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2016, 19 (07) : A538 - A538
  • [2] COST-EFFECTIVENESS ANALYSIS OF FILGOTINIB AS A FIRST-LINE TREATMENT FOR BIOLOGIC-NAIVE PATIENTS WITH ULCERATIVE COLITIS IN GREECE
    Nomikos, N.
    Naoum, P.
    Athanasakis, K.
    Kyriopoulos, I
    VALUE IN HEALTH, 2024, 27 (12) : S80 - S80
  • [3] COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN GREECE
    Kourkoulas, N.
    Athanasakis, K.
    Boubouchairopoulou, N.
    Chouchouli, K.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2018, 21 : S294 - S294
  • [4] MODELLING THE COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR RHEUMATOID ARTHRITIS IN ENGLAND AND WALES
    Righetti, C.
    Lebmeier, M.
    Pennington, B.
    Brereton, N. J.
    VALUE IN HEALTH, 2013, 16 (07) : A578 - A579
  • [5] Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?
    Boers, Maarten
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) : 668 - 669
  • [6] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUS AS FIRST LINE BIOLOGIC MONOTHERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT IN GREECE
    Athanasakis, K.
    Tarantilis, F.
    Skroumpelos, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2015, 18 (07) : A671 - A671
  • [7] A cost-effectiveness analysis of biological treatments for rheumatoid arthritis
    Chiou, CF
    Wanke, L
    Yu, E
    Ofman, J
    VALUE IN HEALTH, 2004, 7 (03) : 223 - 223
  • [8] First-line treatments for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (09): : E507 - E507
  • [9] COST-EFFECTIVENESS OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CHINA
    Wang, B. C.
    Chen, Y.
    Furnback, W.
    Wu, Q.
    Dong, P.
    VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [10] Cost-effectiveness analysis of first-line HAART
    Maggiolo, F.
    Di Matteo, S.
    Masini, G.
    Astuti, N.
    Di Filippo, E.
    Bernardini, C.
    Soavi, L.
    Colombo, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 69 - 70
12345